These findings demonstrated that dysregulation of the miR-30d–SOX4–PI3K-AKT axis is of great importance for the carcinogenesis of pancreatic cancer and might be a potential therapeutic target. The gene discussed is AKT1; the disease is pancreatic neoplasm.